New drug combo targets advanced prostate cancer in early trial
NCT ID NCT05367440
First seen Sep 30, 2025 · Last updated May 24, 2026 · Updated 31 times
Summary
This study tests a new drug called AZD5305 given together with standard hormone therapies for men whose prostate cancer has spread. The main goals are to check safety, find the right dose, and see early signs of whether the combination helps control the cancer. About 174 men with metastatic prostate cancer will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC PROSTATE CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Research Site
Detroit, Michigan, 48201, United States
-
Research Site
Detroit, Michigan, 48202, United States
-
Research Site
Syracuse, New York, 13210, United States
-
Research Site
Myrtle Beach, South Carolina, 29572, United States
-
Research Site
Houston, Texas, 77030, United States
-
Research Site
Houston, Texas, 77094, United States
-
Research Site
Camperdown, 2050, Australia
-
Research Site
Darlinghurst, 2010, Australia
-
Research Site
East Melbourne, 3002, Australia
-
Research Site
Heidelberg, 3084, Australia
-
Research Site
Melbourne, 3004, Australia
-
Research Site
St Leonards, 2065, Australia
-
Research Site
Candiolo, 10060, Italy
-
Research Site
Milan, 20133, Italy
-
Research Site
Orbassano, 10043, Italy
-
Research Site
Padova, 35128, Italy
-
Research Site
Cambridge, CB2 0QQ, United Kingdom
-
Research Site
Glasgow, G12 0YN, United Kingdom
-
Research Site
Manchester, M20 4BX, United Kingdom
-
Research Site
Plymouth, PL6 8DH, United Kingdom
Conditions
Explore the condition pages connected to this study.